ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2. Garcia-Arriaza J, Falqui M, Perez P, Coloma R, et al. Vaccines (Basel) 2025;13:696.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Garcia-Arriaza J, Falqui M, Perez P, Coloma R, et al. ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2. Vaccines (Basel) 2025;13:696.
PMID: 40733673